Mark J. Alles - 24 May 2021 Form 3 Insider Report for Turning Point Therapeutics, Inc.

Role
Director
Signature
/s/ Annette North, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
24 May 2021
Net transactions value
$0
Form type
3
Filing time
26 May 2021, 16:46:49 UTC
Next filing
04 Jun 2021

No securities are beneficially owned.

Remarks:

No securities are beneficially owned.